Correlation Between Spire Healthcare and Ondine Biomedical
Can any of the company-specific risk be diversified away by investing in both Spire Healthcare and Ondine Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spire Healthcare and Ondine Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spire Healthcare Group and Ondine Biomedical, you can compare the effects of market volatilities on Spire Healthcare and Ondine Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spire Healthcare with a short position of Ondine Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spire Healthcare and Ondine Biomedical.
Diversification Opportunities for Spire Healthcare and Ondine Biomedical
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Spire and Ondine is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Spire Healthcare Group and Ondine Biomedical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ondine Biomedical and Spire Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spire Healthcare Group are associated (or correlated) with Ondine Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ondine Biomedical has no effect on the direction of Spire Healthcare i.e., Spire Healthcare and Ondine Biomedical go up and down completely randomly.
Pair Corralation between Spire Healthcare and Ondine Biomedical
Assuming the 90 days trading horizon Spire Healthcare Group is expected to under-perform the Ondine Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Spire Healthcare Group is 4.08 times less risky than Ondine Biomedical. The stock trades about -0.01 of its potential returns per unit of risk. The Ondine Biomedical is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 775.00 in Ondine Biomedical on November 28, 2024 and sell it today you would earn a total of 350.00 from holding Ondine Biomedical or generate 45.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spire Healthcare Group vs. Ondine Biomedical
Performance |
| Timeline |
| Spire Healthcare |
| Ondine Biomedical |
Spire Healthcare and Ondine Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spire Healthcare and Ondine Biomedical
The main advantage of trading using opposite Spire Healthcare and Ondine Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spire Healthcare position performs unexpectedly, Ondine Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ondine Biomedical will offset losses from the drop in Ondine Biomedical's long position.| Spire Healthcare vs. Virgin Wines UK | Spire Healthcare vs. International Consolidated Airlines | Spire Healthcare vs. Scandinavian Tobacco Group | Spire Healthcare vs. Infrastrutture Wireless Italiane |
| Ondine Biomedical vs. Berkshire Hathaway | Ondine Biomedical vs. Samsung Electronics Co | Ondine Biomedical vs. Samsung Electronics Co | Ondine Biomedical vs. Samsung Electronics Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |